Statistical identification of predictors for peripheral neuropathy associated with administration of bortezomib, taxanes, oxaliplatin or vincristine using ordered logistic regression analysis
- PMID: 20679888
- DOI: 10.1097/CAD.0b013e32833db89d
Statistical identification of predictors for peripheral neuropathy associated with administration of bortezomib, taxanes, oxaliplatin or vincristine using ordered logistic regression analysis
Abstract
Chemotherapy-induced peripheral neuropathy (CIPN) is a major drug-induced adverse reaction that becomes a dose-limiting toxicity. However, effective strategies for preventing or treating CIPN are lacking. Accordingly, this study aimed to statistically identify predictors for CIPN. Retrospective analysis was carried out for 190 patients who had been treated with bortezomib (n=28), taxanes (paclitaxel or docetaxel; n=58), oxaliplatin (n=52) or vincristine (n=52) at our hospital between April 2005 and December 2008. The severity of CIPN was assessed at the time of chemotherapy completion, graded as grade 0-5 in accordance with the National Cancer Institute Common Terminology Criteria for Adverse Events v3.0. Multivariate ordered logistic regression analysis was used to investigate predictors for CIPN. Predictors for CIPN in patients that were administered bortezomib were no co-administration of dexamethasone [odds ratio (OR), 0.455; confidence interval (CI), 0.208-0.955; P=0.0376] and sex (male) (OR, 3.035; CI, 1.356-6.793; P=0.0069). For taxanes (paclitaxel or docetaxel), the predictor for CIPN was a large number of chemotherapy cycles (OR, 2.379; CI, 1.035-5.466; P=0.0412). For oxaliplatin, the predictors for CIPN were a large number of chemotherapy cycles (OR, 3.089; CI, 1.598-5.972; P=0.0008) and no co-administration of non-steroidal anti-inflammatory drugs (OR, 0.393; CI, 0.197-0.785; P=0.0082). For vincristine, predictors for CIPN were a large number of chemotherapy cycles (OR, 6.015; CI, 1.880-19.248; P=0.0025) and co-administration of an analgesic adjuvant (OR, 3.907; CI, 1.383-11.031; P=0.0101). In conclusion, our study indicates that CIPN will be alleviated by the co-administration of dexamethasone with bortezomib and non-steroidal anti-inflammatory drugs with oxaliplatin.
Similar articles
-
[Chemotherapy-induced peripheral neuropathy].Gan To Kagaku Ryoho. 2011 Nov;38(11):1773-6. Gan To Kagaku Ryoho. 2011. PMID: 22083183 Japanese.
-
Oral glutamine for the prevention of chemotherapy-induced peripheral neuropathy.Ann Pharmacother. 2008 Oct;42(10):1481-5. doi: 10.1345/aph.1L179. Epub 2008 Aug 12. Ann Pharmacother. 2008. PMID: 18698011 Review.
-
The Total Neuropathy Score as an assessment tool for grading the course of chemotherapy-induced peripheral neurotoxicity: comparison with the National Cancer Institute-Common Toxicity Scale.J Peripher Nerv Syst. 2007 Sep;12(3):210-5. doi: 10.1111/j.1529-8027.2007.00141.x. J Peripher Nerv Syst. 2007. PMID: 17868248
-
Therapy of chemotherapy-induced peripheral neuropathy.Br J Haematol. 2009 Apr;145(1):3-14. doi: 10.1111/j.1365-2141.2008.07558.x. Epub 2009 Jan 16. Br J Haematol. 2009. PMID: 19170681 Review.
-
Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies.Eur J Cancer. 2008 Jul;44(11):1507-15. doi: 10.1016/j.ejca.2008.04.018. Epub 2008 Jun 18. Eur J Cancer. 2008. PMID: 18571399 Review.
Cited by
-
Potential Mediators of Oxaliplatin-Induced Peripheral Neuropathy From Adjuvant Therapy in Stage III Colon Cancer: Findings From CALGB (Alliance)/SWOG 80702.J Clin Oncol. 2023 Feb 10;41(5):1079-1091. doi: 10.1200/JCO.22.01637. Epub 2022 Nov 11. J Clin Oncol. 2023. PMID: 36367997 Free PMC article. Clinical Trial.
-
Peripheral neuropathy caused by Paclitaxel and docetaxel: an evaluation and comparison of symptoms.J Adv Pract Oncol. 2013 Jul;4(4):204-15. J Adv Pract Oncol. 2013. PMID: 25032002 Free PMC article. Review.
-
Marked sexual dimorphism in neuroendocrine mechanisms for the exacerbation of paclitaxel-induced painful peripheral neuropathy by stress.Pain. 2020 Apr;161(4):865-874. doi: 10.1097/j.pain.0000000000001798. Pain. 2020. PMID: 31917777 Free PMC article.
-
Vincristine-Induced Peripheral Neuropathy (VIPN) in Pediatric Tumors: Mechanisms, Risk Factors, Strategies of Prevention and Treatment.Int J Mol Sci. 2021 Apr 16;22(8):4112. doi: 10.3390/ijms22084112. Int J Mol Sci. 2021. PMID: 33923421 Free PMC article. Review.
-
Predictors for development of oxaliplatin-induced peripheral neuropathy in cancer patients as determined by ordered logistic regression analysis.PLoS One. 2022 Sep 29;17(9):e0275481. doi: 10.1371/journal.pone.0275481. eCollection 2022. PLoS One. 2022. PMID: 36174022 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous